Key Highlights
•
Scientists have developed new drugs that block two key proteins, HIF-1 and HIF-2, which tumors use to grow blood vessels, evade the immune system, and spread. These oral drugs not only shrank several types of cancer on their own but also restored the effectiveness of immunotherapy in over half of resistant cases, offering a promising new dual-target strategy.
Source →
•
A new software toolkit called CREsted can now predict how DNA switches called enhancers control which genes are turned on in specific cell types, using data from large-scale single-cell studies. This tool helps decode the complex rules of gene regulation, which is a major step toward understanding development and designing precise medical treatments.
Source →
•
Researchers discovered that a protein complex involving Nemp1 and Nesprin helps cells sense and respond to the stiffness of their surrounding environment. This finding is crucial because it reveals a direct molecular link between physical cues from tissues and cellular behavior, which is important for understanding cancer progression and tissue regeneration.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
